Serotonin syndrome
SSRI plus MAOI combinations flag at order entry. Tramadol, linezolid, and methylene blue also surface.
ePrescribe
Prescribe in the encounter, not in another tab.
Surescripts-certified, with EPCS and real-time benefit checks. Interaction checks are tuned for psych and addiction-medicine combinations.
ePrescribe is a paid add-on, priced per provider. Surescripts onboarding, EPCS identity proofing, and two-factor enrollment happen in the platform. Most solo and small groups prescribe within a week.
Already on Nextvisit? Add ePrescribe from the workspace settings. Sign in to enable.
From order entry to the pharmacy in one card.
Clinics with the new UI get a this-visit pad next to the chart strip. Some clinics still use the older composer.
Patient M.G.
Sertraline HCl 100 mg oral tablet
1 tab PO daily · qty 30 · 1 refill
- AllergiesNKDA on file. No conflicts with sertraline.
- Drug interactionsCross-checked 4 active meds (alprazolam, lithium, propranolol, melatonin). No critical interactions.
- Dose for age and indication50 mg → 100 mg titration appropriate for adult MDD per FDA labeling.
- QTc advisoryBaseline ECG advised if escalating beyond 200 mg or combining with other QT-prolonging agents.
- EPCS not requiredSchedule IV. Standard e-prescribe path applies.
Aetna PPOTier 1$0 copayNo prior auth
SurescriptsCVS Pharmacy #04321
Sample data. Live orders use the patient roster, plan on file, and pharmacy preferences.
Alerts for psych and addiction combinations.
SSRI plus MAOI, lithium plus NSAIDs, QTc stacks, and buprenorphine plus benzodiazepines.
Lithium toxicity
NSAID, ACE inhibitor, and thiazide combinations prompt a level-check reminder. Lithium level cadence follows the dosing pattern on file.
QT prolongation
Citalopram, ziprasidone, methadone, and combinations among them trigger a QTc advisory, with a baseline ECG suggestion when you plan to escalate.
Buprenorphine and benzodiazepines
The combination is not contraindicated. The system surfaces the overdose risk and the documentation requirements at order entry.
Schedule II to V, with two-factor at send.
Immutable audit log. Records that meet DEA 21 CFR 1311.
- Immutable audit log of every send, retraction, and refill.
- Schedule II for stimulants, opioids, and benzodiazepines.
- DEA 21 CFR 1311 EPCS rule compliant.
Tier, copay, and prior auth at order entry.
The patient does not learn the cost at the pharmacy counter.
- Copay estimate (covered amount, deductible status, OOP impact).
- Prior-auth flag, with the form pre-populated when PA is required.
- Therapeutic alternatives when the chosen drug is not covered.
Buprenorphine, naltrexone, and methadone.
The X-waiver ended with the Mainstreaming Addiction Treatment Act in December 2022. Standard DEA registration plus the 8-hour MAT training is enough.
Most behavioral-health clinicians are now MAT-eligible by default. Nextvisit handles EPCS for buprenorphine (Schedule III), prior-auth checks for some payers, and 42 CFR Part 2 documentation. Dedicated MAT panels use cohort tags and outcome tracking on the MAT solutions page .
EPCS, MAT, interactions, and pharmacies.
Nextvisit ePrescribe is Surescripts-certified. It supports EPCS for Schedule II to V, behavioral-health interaction and dose-for-age checks, and routes to the patient's pharmacy.
Yes, for Schedule II to V. Two-factor at every send. The audit log is immutable and meets DEA 21 CFR 1311. Common Schedule II work includes stimulants and, in some states, certain benzodiazepines. Buprenorphine/naloxone combinations are Schedule III.
Yes. The X-waiver ended in December 2022 under the Mainstreaming Addiction Treatment Act. A standard DEA registration and the 8-hour MAT training are enough. Nextvisit handles EPCS, interaction checks, and MAT documentation.
The new prescription is checked against the patient's active meds at order entry. Alerts focus on serotonin syndrome, lithium toxicity, QT prolongation, and benzodiazepine plus opioid combinations.
Yes. It fires at order entry and returns formulary tier, copay estimate, prior-auth flag, and therapeutic alternatives if the drug is not covered. The PA form is pre-populated when one is needed.
Any pharmacy that accepts Surescripts, including CVS, Walgreens, Walmart, Rite Aid, Kroger, independents, and mail-order. Patients pick a pharmacy at any visit.
Surescripts onboarding, plus EPCS identity proofing and two-factor enrollment per provider, handled in the platform. Most solo and small groups prescribe within a week. Enterprise and academic sites that need credentialing-board sign-off run on their own timeline.
Yes, on the medications chart. Switch proposes a day-by-day cross-taper or washout for catalog antidepressants and common behavioral-health antipsychotics, with the reason in plain language. You accept, edit, or reject. MAOI pairs stay on a washout. Mood stabilizers, benzodiazepines, and stimulants are not in this catalog. The schedule is a rules table, not a model, and you still own the prescription.
Try it next visit
Twenty minutes, one mock visit. You leave with a note in your template.
Enable ePrescribe and run an EPCS send against a sandbox pharmacy in the first week.
Live in 2 weeks or less
BAA signed by default